Search Results 101-110 of 16464 for monoclonal antibody

1. Belimumab (intravenous route, subcutaneous route) - Mayo Clinic

   Belimumab injection is used to treat active, autoantibody ... It is a monoclonal antibody that changes the immune system to help control lupus symptoms.

2. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

3. Publications - Raymund R. Razonable, M.D. - Mayo Clinic

   ... monoclonal antibody therapy in solid organ transplant recipients. J Med Virol. 2023 Jun; 95 (6):e28885. View PubMed; Luther VP, Barsoumian AE, Konold VJL ...

4. Strategy for Improving Stroke Treatment Response - Mayo Clinic

   The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in ...

5. Hong Qin, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Qin's antibody discovery research is focused on developing monoclonal antibodies against both well‐characterized and unknown antigens. To accomplish the former ...

6. Idecabtagene vicleucel (intravenous route) - Mayo Clinic

   ... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Idecabtagene vicleucel injection is an antineoplastic ...

7. A Study to Compare Nivolumab or Brentuximab Vedotin Plus Combination Chemotherapy to Treat Patients with Newly-diagnosed Stage III-IV Classic Hodgkin Lymphoma - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as ... Brentuximab vedotin is a monoclonal antibody, brentuximab, linked to a toxic agent called vedotin.

8. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. Participation eligibility. Participant eligibility includes age, gender, type ...

9. Potential one-time gene therapy treatment for wet age-related macular degeneration - Mayo Clinic

   ... monoclonal antibody fragment," says Dr. Bakri. "The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity. Anti ...

10. Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic

    ... monoclonal antibody therapy prior to anti-EGFR monoclonal antibody therapy. For those with left-sided tumors, the data are less clear. However, we at least ...